Robert I. Levy Prof. of Cardiology, Assoc. Chief, Cardiovascular Medicine, Yale U. School. of Medicine
Cardiology
Dr. Jeffrey R. Bender, MD
|
|
Give Review
Jeffrey R. Bender practices Cardiology. He graduated from University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical university. University of California San Francisco School of Medicine is ranked 3 in research and 3 in primary care medicine He received 1 awards: "Elected Member". Jeffrey Bender is also a published doctor. He has 78 paper published. The most recent paper is: Lymphotoxin alpha3 induces chemokines and adhesion molecules: insight into the role of LT alpha in inflammation and lymphoid organ development. Doctor Jeffrey R. Bender, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Ceramide-Activated Phosphatase Mediates Fatty Acid-Induced Endothelial VEGF Resistance and Impaired Angiogenesis.
- Endothelial estrogen receptor isoforms and cardiovascular Disease.
- Molecular imaging of vascular endothelial growth factor receptors in graft arteriosclerosis.
- Splice Isoform Estrogen Receptors as Integral Transmembrane Proteins.
- VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling.
- T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascade.
- Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating re...
- Vascular cell signaling by membrane estrogen receptors.
- Rac, PAK, and eNOS ACTion.
- Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development.
- Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation.
- Activated alphavbeta3 integrin targeting in injury-induced vascular remodeling.
- Pathophysiology of leukocyte-tissue interactions.
- LFA-1-dependent HuR nuclear export and cytokine mRNA stabilization in T cell activation.
- Dynamic partitioning into lipid rafts controls the endo-exocytic cycle of the alphaL/beta2 integrin, LFA-1, during leukocyte chemotaxis.
- Alphavbeta3-targeted detection of arteriopathy in transplanted human Coronary arteries: an autoradiographic study.
- Cytokines and cardiovascular Disease.
- Rapid, estrogen receptor-mediated signaling: why is the endothelium so special?
- Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo.
- Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells.
- Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen.
- Rapid vascular cell responses to estrogen and membrane receptors.
- Idiopathic dilated cardiomyopathy. An immunologic, genetic, or infectious Disease, or all of the above?
- Monoclonal antibodies reactive with subsets of mouse and human thymic epithelial cells.
- Ex vivo evaluation of PBMNCs collected with a new cell separator.
- Retroviral gene transfer: effects on endothelial cell phenotype.
- Endothelial cell seeding influences lesion development following arterial injury in the cholesterol-fed rabbit.
- ESDN is a marker of vascular remodeling and regulator of cell proliferation in graft arteriosclerosis.
- Vascular cell adhesion molecule-1-targeted detection of endothelial activation in human microvasculature.
- Evidence that cytotoxic lymphocytes alter and traverse allogeneic endothelial cell monolayers.
- COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1.
- Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer...
- Endothelial cell class II HLA expression induced by cytotoxic lymphocytes is regulated by genetically determined differences in CD11a/CD18.
- Epican, a heparan/chondroitin sulfate proteoglycan form of CD44, mediates cell-cell adhesion.
- Initiation of cardiac allograft rejection New developments in cellular and molecular mechanisms.
- Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis.
- Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis.
- Tumor necrosis factor alpha-induced vascular leakage involves PECAM1 phosphorylation.
- Overlapping recognition of xenogeneic carbohydrate ligands by human natural killer lymphocytes and natural antibodies.
- Antigen-receptor complex stimulation triggers protein kinase C-dependent CD11a/CD18-cytoskeleton association in T lymphocytes.
- Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers.
- Through and beyond the wall: late steps in leukocyte transendothelial migration.
- Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues.
- Cellular early immune recognition of xenogeneic vascular endothelium.
- Membrane-initiated actions of estrogen on the endothelium.
- Lymphocyte subsets differentially induce class II human leukocyte antigens on allogeneic microvascular endothelial cells.
- Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression.
- Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes.
- Lymphotoxin alpha3 induces chemokines and adhesion molecules: insight into the role of LT alpha in inflammation and lymphoid organ development.
- Minireview: estrogen receptor-mediated rapid signaling.
- Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors.
- Molecular mechanisms of estrogen actions on the vasculature.
- Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery Disease.
- A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2.
- T-cell receptor-negative natural killer cells display antigen-specific cytotoxicity for microvascular endothelial cells.
- Heterogeneous activation thresholds to cytokines in genetically distinct endothelial cells: evidence for diverse transcriptional responses.
- Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis.
- Integrin-dependent regulation of gene expression in leukocytes.
- Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement.
- Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-gamma-dependent and -independent mechanisms.
- Early recognition of a discordant xenogeneic organ by human circulating lymphocytes.
- Signal requirements for the generation of CD4+ and CD8+ T-cell responses to human allogeneic microvascular endothelium.
- Anchorage dependence of mitogen-induced G1 to S transition in primary T lymphocytes.
- Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines.
- Feedback modulation of ligand-engaged alpha L/beta 2 leukocyte integrin (LFA-1) by cyclic AMP-dependent protein kinase.
- Heterogeneous distribution and transmembrane signaling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets.
- Lymphocyte adhesion-dependent calcium signaling in human endothelial cells.
- A tyrosine-based sorting signal in the beta2 integrin cytoplasmic domain mediates its recycling to the plasma membrane and is required for ligand-supported migration.
- Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture.
- CD28 and LFA-1 contribute to cyclosporin A-resistant T cell growth by stabilizing the IL-2 mRNA through distinct signaling pathways.
- Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: involvement of an inhibitory G protein.
- Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells.
- Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release.
- Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling.
- Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion.
- Conserved regions in the cytoplasmic domains of the leukocyte integrin alpha L beta 2 are involved in endoplasmic reticulum retention, dimerization, and cytoskeletal a...
- 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization.
Schools
University Of California San Francisco School Of Medicine
Yale New Haven Hospital
Stanford University
Procedures Preformed
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Thoracentesis
Conditions Treated
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomegaly
- Cardiomyopathy
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Elected Member
Education
-
Yale-New Haven Hospital -
University of California San Francisco School of Medicine
Hospital
-
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1417947987 | |
| NPPES Provider LastName | BENDER | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 065191369 | |
| NPPES Provider State | CT | |
| Specialty Description | Cardiology | |
| Total Claim Count | 19.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417947987 |
| Last Name Of The Provider | BENDER |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. Kabul S. Garg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barry L. Zaret, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dragos V. Balf, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nathan A. Kruger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lavanya Bellumkonda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark L. Blitzer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Chrissoheris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Foley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harlan M. Krumholz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jordan C. Kawano, MD |
|
|
Dr. Sarah C. Hull, MD |
|
|
Dr. Samuel S. Hahn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oliver J. Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vaibhav Medhekar, MD |
|
|
Dr. Qi Zheng, MD |
|
|
Dr. Peter S. Yoo, MD
This Doctor is OpenDoctor Recommended.
|